There
is “a time to be born and a time to die . . .” Each day, the body’s
cells—particularly, the skin and blood cells, are being produced anew. Since
their total number must be kept constant, a mechanism must be in place to
maintain a balance and remove any redundant cells. This mechanism, programmed
cell death (PCD), is an orderly, highly regulated process that functions to
keep normal cell division (mitosis) in check. There are other conditions in
which removal of cells—such as those that are old, diseased, or damaged from
exposure to toxic materials or radiation—benefits the organism. During
menstruation, the body sheds the lining of the uterus. By contrast, inadequate
PCD can lead to the spread of cancer or, for instance, babies born with fingers
still joined.
Responding
to signals arising from outside and within the cell to initiate PCD, the cell
undergoes a reduction in size as its components break down and condense. These
cell fragments (apoptotic bodies) become enclosed in a membrane, walling them
off and preventing them from damaging nearby cells. Phagocytic cells then
engulf and destroy the fragments.
Carl
Vogt, a German biologist working in Switzerland, was first to describe the
concept of PCD in 1842 while studying the development of tadpoles. In 1885, Walther
Flemming, another biologist, described this phenomenon in more precise detail;
Flemming’s fame rests on his discovery of mitosis and chromosomes, one of the
most significant discoveries in cell biology and in all of science. Interest in
PCD was revived in 1965, when the Australian pathologist John Foxton Ross Kerr
first described the ultramicroscopic characteristics of PCD and how it was a
normal process that differed from necrosis caused by tissue injury. It was Kerr
who was first to refer to PCD as apoptosis, from the Greek “falling off,” as
petals or leaves. During the 1970s, John E. Sulston, H. Robert Horvitz, and
Sydney Brenner, working at Cambridge University and studying the genetic
sequence of roundworms, gained an understanding of apoptosis at a molecular
level; the three were co-recipients of the 2002 Nobel Prize.
No comments:
Post a Comment